Addressing the Full Spectrum of Cardiovascular Disease Complexity

The SYNERGY™ Bioabsorbable Polymer (BP) Stent is being studied in 20 investigator-sponsored research trials including more than 30,000 patients, allowing physicians worldwide to provide data on patients receiving the SYNERGY BP Stent.

We are investing in the science to address significant unmet clinical needs. We are the only company running an IDE trial to evaluate a 3-month DAPT regimen in BP-DES patients with a high bleeding risk.